Business Wire

TMD Security Establishes TMS ATM Software, Global Provider of ATM Management Solutions

Jaa

TMD Security announced today it has established TMS ATM Software in partnership with S3 Technologies Ltd., an APAC based ATM management software company with a ten-year track record that includes multi-vendor ATM management and monitoring software solutions for all major brands of ATMs, cash deposit and recycling machines. TMS ATM Software has headquarters in the Netherlands, R&D in APAC and sales and support globally.

‘The ATM industry needs a more cost effective way to fully protect the ATM channel,’ said Cees Heuker of Hoek, Founder, TMD Security and Co-Founder and CEO, TMS ATM Software. ‘Software is now the heartbeat of all that we do. Hardware alone is not enough anymore. It takes a combination of the best hardware and software to design security solutions that help ATM deployers cost effectively secure their ATMs. Our TMD Security credentials together with the proven expertise of TMS ATM Software mean that our customers and partners will get the best of both worlds. We are in a unique position to take ATM security to the next level. The industry also needs a more cost effective and efficient approach to ATM management – and now we have it with TMS ATM Software. With flexible software-as-a-service (SaaS) pricing customers can be confident that they only pay for what they need.’

TMS ATM Software protects against logical attacks involving malware or ‘black box’ devices that are used to jackpot the ATM. Security Management Software detects unauthorised software or hardware changes with Profile Management and blocks the use of non-approved USB mass storage devices, controls Windows access to the ATM and helps the bank to securely manage BIOS passwords with Access Management.

A ‘one-look’ dashboard helps deployers see the status of all their ATMs, including security, and a mobile app helps to resolve issues fast while service personnel are on the move and reduces service call costs.

‘TMD Security chose this partnership to build a new global software company because of our software excellence,’ said Stanley Teo, Co-Founder, TMS ATM Software and CEO, S3 Technologies Ltd. ‘Our flexibility in customising and delivering specific solutions for our customers is based on more than a decade of ATM industry experience. Our software has helped customers in APAC to reduce their operational costs, improve ATM availability and deliver the best customer service, despite tight budgets and low network bandwidth challenges – no matter which ATM vendor they choose.’

TMD Security’s combined hardware and software security portfolio not only includes Card Protection Kit (CPK) anti-skimming solutions but also Gas Defence Kit (GDK) and Note Staining Kit (NSK) that defend against gas and solid explosive attacks. New solutions to be introduced this year include TMD Lock, an intelligent and secure way to protect the top box and vault from logical and traditional physical attacks, whilst saving costs on key and password management.

TMD Security and TMS ATM Software will share insight into how to defend against the latest global ATM threats and how ATM Management and Monitoring can help improve operational efficiency at RBR Self-Service Banking Asia in Jakarta 21-22 March 2018.

Company profile

TMD Security and TMS ATM Software are headquartered in Europe, with R&D, sales and support in EMEA, APAC and Americas.

www.tmdsecurity.com; email: atmprotection@tmdsecurity.com

www.tmsatmsoftware.com; email: sales@tmsatmsoftware.com

Contact information

TMD Security
Claire Shufflebotham
c.shufflebotham@tmdsecurity.com
+44 (0)7791 091876

Tietoja julkaisijasta

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Tilaa tiedotteet sähköpostiisi

Haluatko tietää asioista ensimmäisten joukossa? Kun tilaat mediatiedotteemme, saat ne sähköpostiisi välittömästi julkaisuhetkellä. Tilauksen voit halutessasi perua milloin tahansa.

Lue lisää julkaisijalta Business Wire

AURAK Gains SACSCOC Accreditation15.12.2018 13:49Tiedote

The Southern Association of Colleges and Schools Commission on Colleges (SACSCOC) officially announced the accreditation of the American University of Ras Al Khaimah (AURAK) at its 2018 Annual Meeting which was held in New Orleans, Louisiana, in the United States of America. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181215005017/en/ AURAK delegation during the SACSCOC conference in New Orleans” (Photo: AETOSWire) SACSCOC, the regional body for the accreditation of degree-granting higher education institutions in the Southern United States, has a membership of more than 800 institutions in the Southern states and other international sites approved by SACSCOC that award associate, baccalaureate, master’s, and/or doctoral degrees. SACSCOC also awards accreditation to other international institutions of higher education that satisfy all its requirements and demonstrate compliance with its accreditation standards. AURAK now

Lehman Brothers Treasury Announces Plans for Partial Wind-Down14.12.2018 20:41Tiedote

Lehman Brothers Treasury Co. B.V. in liquidation (“LBT”) today, through its U.S. counsel Kramer Levin Naftalis & Frankel LLP, announced that LBT is planning a final cash distribution to its creditors. Professional holders of eligible notes will have the option to retain their investment by electing to receive substitute notes of one (or a few) series. Such election shall take place through a solicitation process. As a consequence, LBT will be able to reduce the number of series of notes outstanding from more than 3,700 to one or a few. Noteholders electing to receive substitute notes will be afforded the same economic entitlement to distributions received by LBT from Lehman Brothers Holdings Inc. (“LBHI”) through the substitute notes. The substitute notes will be denominated in U.S. dollars and future distributions will be made in U.S. dollars only. Noteholders who are not professional investors, or hold notes that are not eligible for substitution, or do not elect to receive substitut

Takeda Receives Positive CHMP Opinion for ADCETRIS® (brentuximab vedotin) for the Treatment of Adult Patients with Previously Untreated CD30+ Stage IV Hodgkin Lymphoma in Combination with AVD14.12.2018 20:00Tiedote

Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for the extension of the marketing authorization of ADCETRIS (brentuximab vedotin) and recommended its approval in combination with AVD in adult patients with previously untreated CD30+ Stage IV Hodgkin lymphoma. ADCETRIS is an antibody-drug conjugate (ADC) directed at CD30, a defining marker of Hodgkin lymphoma. ADCETRIS is currently not approved as a therapy for previously untreated Hodgkin lymphoma in Europe. “For a large number of previously untreated Hodgkin lymphoma patients diagnosed with Stage IV disease, progression will occur with current treatments, highlighting a true unmet need in this population,” said Anna Sureda, M.D., Ph.D., Head of the Hematology Department and Hematopoietic Stem Cell Transplant Programme, Institut Català d'Oncologia - Hospital Duran i Reynals. “In the ECHELON-1 cl

Diamond CBD, POTN Subsidiary, Enters the $46 Billion Coffee Market With the Release of Premium Line of CBD-Infused Coffee & Tea K-Kup Capsules14.12.2018 18:42Tiedote

Diamond CBD Inc., wholly owned subsidiary of PotNetwork Holdings, Inc. (OTC Pink: POTN), a leader in hemp extraction and innovative CBD products for the wellness market, enters the Coffee segment, an industry expected to reach revenues of $46 Billion in 2018. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181214005308/en/ Experience a cup of Chill (Photo: Business Wire) Produced in accordance with a universal K-Cup design, these pods fit in almost all modern single cup coffee makers, making it an easily integrated enhancement to any environment, delivering 25mgs of CBD in a tasty favorite beverage at less than $5 per cup. This new line of premium Chill Coffee Capsules was recently added to the Company’s broad range of cannabinoid and natural hemp products. Each box comes with 4 individual capsules in original chill coffee, decaf chill coffee, chill black tea, and chill green tea flavors. The unit price for each box is $10.00

Henley & Partners Enlarges Executive Committee to Manage Expansion and Growth14.12.2018 17:00Tiedote

Residence- and citizenship-by-investment programs have firmly established themselves over the past few years as the new frontier in terms of freedom, flexibility, and future-readiness, both for the countries issuing these programs and for the individual investors participating in them. The societal and economic value these programs generate is undisputed. The investment migration industry as a whole is currently grossing roughly USD 18 billion per year, with an expectation that it will hit the USD 20 billion mark very soon. Foreign direct investment (FDI) is now considered the lifeblood of economic growth for many developing and recovering smaller countries around the world. As such, the number of investment migration programs has been increasing rapidly, from just a handful of programs in the 1980s and 1990s to over 100 countries that now have investment migration provisions in their laws. There are more than 60 active programs today, with Moldova and Montenegro — both fast-growing Eu

Vargatef® plus docetaxel could be an option after failure of immunotherapy in lung cancer14.12.2018 12:07Tiedote

Boehringer Ingelheim announced today the first interim results of VARGADO, an ongoing non-interventional study in routine clinical practice in Germany evaluating the efficacy and safety of Vargatef® (nintedanib) and docetaxel in patients with stage III/IV locally advanced or metastatic non-small cell lung cancer (NSCLC) of adenocarcinoma histology. The study consists of three cohorts, two of which allow for prior treatment with immune checkpoint inhibitors (ICIs) either in combination with chemotherapy in the first-line or as monotherapy in the second-line of treatment. The interim results from Cohort B (first-line chemotherapy, second-line immune checkpoint inhibitors, third-line Vargatef® plus docetaxel) were presented today at ESMO Immuno-Oncology Congress 2018 in Geneva.1 Despite a limited sample size, the VARGADO study adds to the body of evidence for nintedanib in lung adenocarcinoma following pre-treatment with chemotherapy and ICIs.1,3 The addition of nintedanib to docetaxel ha

Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.

Tutustu uutishuoneeseemme